Using EMI-137 for Detecting Dysplasia in Barrett’s Esophagus
Author Information
Author(s): Huang Yi-Jhih, Rieder Jonas, Tan Kel Vin, Tenditnaya Anna, Vojnovic Borivoj, Gorpas Dimitris, Quante Michael, Vallis Katherine A.
Primary Institution: Department of Oncology, University of Oxford, Oxford, United Kingdom
Hypothesis
Can EMI-137 effectively detect dysplastic lesions in Barrett’s esophagus?
Conclusion
EMI-137 accumulates in dysplastic lesions within Barrett’s esophagus and has potential as a screening tool.
Supporting Evidence
- EMI-137 showed strong accumulation in dysplastic lesions in a mouse model.
- c-MET expression was significantly higher in Barrett’s esophagus compared to normal tissue.
- Fluorescence molecular endoscopy allowed for real-time imaging of dysplastic lesions.
Takeaway
This study shows that a special dye can help doctors find early signs of cancer in the esophagus more easily.
Methodology
The study used a dual xenograft mouse model and fluorescence molecular endoscopy to evaluate EMI-137's effectiveness.
Potential Biases
Potential bias in the interpretation of fluorescence imaging results due to the limitations of the preclinical setup.
Limitations
The study's findings may not fully translate to human patients due to differences in the mouse model and imaging techniques.
Participant Demographics
Mice aged 4 to 16 months, both male and female.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website